Exchange: NASDAQ·Updated 07:32 PM EST
WHWK logo

WHWK Whitehawk Therapeutics Inc.

$3.08
$0.05
(1.63%)
Today
Closed $3.01
$0.07
(2.33%)
After Hours
Reported EarningsNov 9
Mkt Cap$180.57M
Vol261,784.00

About WHWK

Whitehawk Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Morristown, NJ.
43

Bearish Sentiment

How do you feel about WHWK?

StocktwitsEarnings
$WHWK Q3 '26 Earnings Results & Recap Whitehawk Therapeutics believes its $169.7M in cash, cash equivalents and short-term investments will enable planned operations into the second half of 2028, and does not expect revenue for the foreseeable future.

Advertisement|Remove ads.